Lack of correlation between calcium intake and serum calcium levels in stable haemodialysis subjects

Nephron - Clinical Practice

Volumn 113, Issue 3, 2009, Pages

  Byrne, Fiona N ^a   Kinsella, Sinead ^a   Murnaghan, Dermot J ^a   Kiely, Mairead ^b   Eustace, Joseph A ^a  

^a University College Cork and INFANT Centre   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Calcium intake; Dialysis; Diet; Phosphate binders; Serum calcium; Vascular calcification

Indexed keywords

ALBUMIN; CALCIUM; PARATHYROID HORMONE;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RELIABILITY;

ADULT; AGED; BIOLOGICAL MARKERS; CALCIUM; CALCIUM, DIETARY; FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 68349106837     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000232597     Document Type: Article

References (30)

1. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in endstage renal disease. Hypertension 2001; 38: 938-942.
2. Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM: Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007; 71: 438-441.
3. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P: Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005; 68: 1815-1824.
4. Chertow GM, Burke SK, Raggi P: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62: 245-252.
5. Guerin AP, London GM, Marchais SJ, Metivier F: Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000; 15: 1014-1021. (Pubitemid 30410374)
6. Qunibi W, Moustafa M, Muenz LR, He DY, Kessler PD, Diaz-Buxo JA, Budoff M: A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am J Kidney Dis 2008; 51: 952-965.
7. McCullough PA, Sandberg KR, Dumler F, Yanez JE: Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: A systematic review. J Nephrol 2004; 17: 205-215.
8. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218.
9. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006; 70: 771-780.
10. Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, Klag MJ, Powe NR: Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study. Kidney Int 2006; 70: 351-357.
11. Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK: Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2008;52(3):519-530
12. Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, Kurokawa K, Bommer J, Piera L, Port FK: Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005; 67: 1179-1187.
13. Gotch F: Calcium and phosphorus kinetics in hemodialysis therapy. Contrib Nephrol 2008; 161: 210-214.
14. McIntyre CW: Calcium balance during hemodialysis. Semin Dial 2008; 21: 38-42.
15. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes FaNBIoM: Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, D.C., National Academy Press, 1997.
16. Houillier P, Froissart M, Maruani G, Blanchard A: What serum calcium can tell us and what it can't. Nephrol Dial Transplant 2006; 21: 29-32.
17. Moe SM, Chertow GM: The case against calcium-based phosphate binders. Clin J Am Soc Nephrol 2006; 1: 697-703.
18. Gallieni M, Cozzolino M: Calcium and phosphate: Serum levels versus body balance. Kidney Int 2008; 74: 246-247.
19. Kurz P, Monier-Faugere MC, Bognar B, Werner E, Roth P, Vlachojannis J, Malluche HH: Evidence for abnormal calcium homeostasis in patients with a dynamic bone disease. Kidney Int 1994; 46: 855-861.
20. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC: Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 2004; 15: 1943-1951.
21. Holland B, Welch AA, Unwin ID, Buss DH, Paul AA, Southgate DAT: McCance and Widdowson's The Composition of Foods, ed 5. Suffolk, The Royal Society of Chemistry, 1991.
22. Harrington KE, McGowan MJ, Kiely M, Robson PJ, Livingstone MB, Morrissey PA, Gibney MJ: Macronutrient intakes and food sources in Irish adults: Findings of the North/ South Ireland Food Consumption Survey. Public Health Nutr 2001; 4: 1051-1060.
23. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 2003; 42:S1-S202.
24. Yang H, Curinga G, Giachelli CM: Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int 2004; 66: 2293-2299.
25. Coburn JW, Koppel MH, Brickman AS, Massry SG: Study of intestinal absorption of calcium in patients with renal failure. Kidney Int 1973; 3: 264-272.
26. Wiegmann TB, Kaye M: Malabsorption of calcium and phosphate in chronic renal failure: 32P and 45Ca studies in dialysis patients. Clin Nephrol 1990; 34: 35-41.
27. Mountokalakis TH, Singhellakis PN, Alevizaki CC, Virvidakis K, Ikkos DG: Relationship between degree of renal failure and impairment of intestinal calcium absorption. Nephron 1976; 16: 20-30.
28. Ramirez JA, Emmett M, White MG, Fathi N, Santa Ana CA, Morawski SG, Fordtran JS: The absorption of dietary phosphorus and calcium in hemodialysis patients. Kidney Int 1986; 30: 753-759.
29. Sheikh MS, Maguire JA, Emmett M, Santa Ana CA, Nicar MJ, Schiller LR, Fordtran JS: Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study. J Clin Invest 1989; 83: 66-73.
30. Sheikh MS, Ramirez A, Emmett M, Santa AC, Schiller LR, Fordtran JS: Role of vitamin D-dependent and vitamin D-independent mechanisms in absorption of food calcium. J Clin Invest 1988; 81: 126-132.